AZIN1 and cancer: Together, either IL-6 exposure or continuous lenalidomide treatment enhanced A-to-I editing of GLI1 as well as other cancer-associated associated transcripts, including APOBEC3D, AZIN1, and MDM2 (Supplementary Fig. 4d, g).